Author: Seren Capital

Zenzic Capital announces growth capital facility to experienced UK self-storage independent

Zenzic Capital is delighted to announce that Away Cheltenham Ltd, a self-storage developer/owner/operator, trading under the StoreAway brand, has secured an undisclosed amount of growth capital from Zenzic Capital, in conjunction with Nash Business Capital. 

Established by a team of self-storage management and property experts, StoreAway offers flexible storage space in city centres and urban settings by repurposing unoccupied retail and leisure outlets. To date, the funding partners have supported the acquisition of long-leasehold sites in Cheltenham and Basildon, a freehold property in Bath, and leaseholds in Liverpool and Birmingham.

The StoreAway concept embraces technology, offering advanced control systems that allow users to access self-storage solutions 24 hours a day, seven days a week via a smartphone app with the option of sharing entry with friends and family through a tailored approach. Supporting the launch and operations of each site is leading independent storage consultancy Engage, who has built a respected reputation amongst the storage community over the past decade.

Special recognition
Special recognition goes to our legal representatives at Charles Russell Speechlys LLP. >

“We are delighted to support StoreAway in their growth trajectory. Our special situations strategy continues to deliver to a market that has been suffering from the current macro-conditions, and Zenzic is committed to keep assisting strong platforms and management teams with their expansion plans.”

Zenzic Capital’s Giovanni Larcher

Read More

Zenzic Capital announces £880k senior development facility to experienced developer.

Zenzic Capital announces £880k senior development facility to experienced developer for redevelopment of end-terrace property in North London. 

Zenzic Capital is delighted to announce the completion of an £880k senior development facility to an experienced developer, Luca Garratt, for the redevelopment of an end-terrace house in North London. Completion took place on the 9th of December 2022. The scheme will provide 3 apartments which will deliver a GDV of £1.36m.

Antler’s Managing Director, Andrew Rinaldi, said: “We continue to value our relationship with Zenzic Capital, whose resourcefulness and solution-driven approach match our business model and future growth plans. Our thanks to Zenzic’s team.”

Special recognition goes to:

  • Saam Lowni at Merryoaks for introducing the deal;
  • Konstantinos Polykarpou and Bob Branscombe of Zenzic;
  • Our legal representatives at TLT LLP;
  • Julienne Coffey at Bishop & Sewell LLP.

About Zenzic Capital:
Zenzic Capital is a principal real-estate lender focused on providing innovative financial solutions to high growth real estate groups and developers.  


“We are delighted to commence our collaboration with the developer. Our stretch senior product strategy continues to deliver to a market that has been suffering from the current macro-conditions, and Zenzic is committed to keep assisting developers with their growth plans.”

Zenzic Capital’s Investment Director, Theo Theodosiadis

Read More

Life Science Real Estate

Speed Read
  • Rapid biotech advances, an ageing population, and record investment levels are creating huge demand for life science real estate.  
  • Recent transactions and trends in public markets suggests superior total returns and asset pricing for life science relative to other real estate sub-sectors. 
  • Existing supply is insufficient to meet existing demand even before anticipated growth is factored in. 
  • The life science sector has strong recession-resistant credentials (in terms of occupancy and NOI performance), although conditions in individual markets can vary depending on supply considerations. 
  • An increased allocation to life science property may improve long-term performance and risk-adjusted returns for real estate portfolios. 
  • In our view, given current pricing of completed stock and current supply levels, investors should be able to capture a healthy premium via financing development of new life science real estate. 
  • Additionally, it provides investors the opportunity to contribute to the growth of an industry that will be vitally important to society over the coming decades. 

Two years after the onset of the COVID-19 pandemic, the importance of a high class life science industry is self-evident. Yet the scale of the industry, and the resources required to sustain it, are perhaps still underappreciated. 

Download the full article


Read More